Academic medical centers run investigator-initiated, industry-sponsored, NIH-funded, cooperative-group, and foundation-funded studies on infrastructure that varies department by department. PrismCDM is the regulated operating substrate that unifies Trial Intelligence, execution, evidence, and submission readiness across the institution while respecting the structural realities of AMC governance.
Academic medical centers coordinate clinical research across departments, IRBs, cooperative groups, and industry sponsors, on infrastructure that was never designed to give the institution a single regulated view.
PrismCDM is the regulated operating substrate the institution operates on; departments, PIs, and cooperative-group affiliations are tenant-scoped consumers of that substrate. The institution gets a single inspectable view without flattening departmental governance.
One operating model regardless of how the study is funded. Investigator-initiated, industry-sponsored, NIH-funded, cooperative-group, foundation-funded, all on the same regulated substrate with departmental and IRB scoping enforced at the data layer.
Faculty investigators receive immediate operational guidance without waiting for centralized review, while institutional operations works from the same underlying intelligence.
Every value carries an evidence classification, every artifact carries integrity anchors. Institutional QA, regulatory, and audit teams can independently verify the operational record across departments.
Tenant scoping supports the actual structure of an AMC: multiple PIs, multiple IRBs, multiple departmental owners, multiple cooperative-group affiliations, all on the same substrate.
The Inspection Evidence Package is generated on demand for any study, any department, any auditor. Continuous accumulation replaces audit-time reconstruction.
PrismCDM operates alongside cooperative-group infrastructure, sponsor stacks, and the EDCs already required by industry contracts. No rip-and-replace of established workflows.
Academic medical centers compete for grants, train the next generation of investigators, and run studies that industry cannot. PrismCDM applies the same regulated operating substrate to the protocols faculty author themselves.
Generate Trial Intelligence for internally authored protocols with the same rigor applied to industry-sponsored studies. Faculty bring their protocol; PrismCDM brings the operating substrate.
Help investigators move from protocol development to study execution with consistent operational support across the institution. The substrate that runs a Phase 3 sponsor study also runs the investigator-initiated pilot.
Departments, PIs, and individual studies roll up into one institutional research view, without flattening departmental governance.
Three reasons academic medical centers adopt PrismCDM. The reasons their leadership teams remember after the room clears.
One consistent view of research quality, operational readiness, and regulatory posture across departments, IRBs, and PIs.
Faculty bring the protocol; PrismCDM brings the operating substrate. Investigator-initiated research operates with the same discipline as sponsored trials.
Industry-sponsored, NIH-funded, cooperative-group, foundation-funded. The operating model is the same; the governance is preserved.
